Company Filing History:
Years Active: 2019-2022
Title: Innovations by James Lo in Regulating Pancreatic Beta Cell Function
Introduction
James Lo is an accomplished inventor based in Charlestown, MA (US). He has made significant contributions to the field of metabolic disorders, particularly in the regulation of pancreatic beta cell function. With a total of 2 patents to his name, his work is pivotal in advancing medical science.
Latest Patents
James Lo's latest patents focus on compositions and methods for regulating pancreatic beta cell function using adipsin. The first patent provides compositions and methods for modulating adipsin activity and/or expression. This invention also includes methods for preventing, treating, diagnosing, and prognosing metabolic disorders, such as diabetes, in a subject through modulation or detection of adipsin activity and/or expression. The second patent mirrors the first, emphasizing the importance of adipsin in managing pancreatic beta cell function and its implications for metabolic health.
Career Highlights
James Lo is associated with the Dana-Farber Cancer Institute Inc., where he continues to innovate and contribute to research in metabolic disorders. His work is recognized for its potential impact on diabetes treatment and management.
Collaborations
James Lo collaborates with notable professionals in his field, including Bruce M. Spiegelman. Their combined expertise enhances the research and development of effective treatments for metabolic disorders.
Conclusion
James Lo's innovative work in regulating pancreatic beta cell function through adipsin modulation represents a significant advancement in the fight against metabolic disorders. His contributions are vital for future developments in diabetes treatment and management.